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misconceptions are true today. The results of the study being reviewed emphasises
the importance of such patients being referred to major centers.
In my opinion the morbidity rates can be improved significantly even though
most of the complications were minor. Operative mortality should be below 5%
in expert hands. When one notes that 30% of the patients with solitary tumours
and as many as 18% of the patients with multiple tumours survived 5 years this
provides convincing evidence favouring liver resection. Note that the resection of
colorectal metastases in the liver is probably more justified than surgery for many
other types of malignant lesions including primary surgery for gastric or pancreatic
carcinoma. I hope that an awareness of these results will change the referral pattern
in many areas of the world.
S. Bengmark
Dept of Surgery
Lund University
221 85, Lund, Sweden
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ABSTRACT
Patients with biliary obstruction due to malignant disease, and judged unfit for open
operation, were randomised to have a biliary stent inserted either endoscopically
via the papilla of Vater or percutaneously. Analysis after 75 patients had been
entered showed that the endoscopic method had a significantly higher success rate
for relief of jaundice (81% versus 61%, p 0.017) and a significantly lower 30-day
mortality (15% versus 33%, p 0.016). The higher mortality after percutaneous
stents was due to complications associated with liver puncture (haemorrhage and
bile leaks). When stenting is indicated in elderly and frail patients the endoscopic
method should be tried first.168 HPB INTERNATIONAL
ESSAYIST’S SUMMARY
75 patients with malignant biliary obstruction deemed unfit or technically unsuit-
able for a biliary bypass operation were randomised to have a biliary stent inserted
either endoscopically (EP) or via the percutaneous transhepatic route (PTE).
Patients were referred from many hospitals in and around London but stents
were inserted at only two centres (The London and Middlesex Hospitals by gas-
troenterologists and radiologists with considerable experience in either techniques.
The two treatment groups, EP 39 patients and PTE 36 patients were comparable
with regard to age, ASA grading and other important risk factors in jaundiced
patients. More patients with hilar lesions however were randomised to EP. His-
tological confirmation was obtained in 65% of the patients.
Endoscopic stenting proved to be superior to PTE in several respects; (1) initial
successful placement (EP 89%; PTE 76%) (2) effective drainage, (EP 30/37 (81%),
PTE 20/33 (61%). p 0.017). (3) early complications (EP 7 (19%) of 37 patients
and PTE 22 (67%) out of 33 patients) and (4) 30 day mortality (EP 15% versus
PTE 33%). Nine of the 13 patients in the PTE group where drainage failed de-
veloped complications and there were 9 deaths amongst these patients. The 7
failures in the EP group led to 1 complication and 2 deaths.
The overall median survival in the two groups was short (EP 119 days; PTE 88
days. NS), particularly amongst patients with hilar lesions (EP 65 days, PTE 24
days). The survival was appreciably better in those patients with successfully placed
stents (EP. 159 days and PTE 113 days). There was no difference in the stent
patency rate in the two groups.
PAPER DISCUSSION
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The development of non-operative stenting techniques has initiated a new era in
the treatment of advanced malignant biliary obstruction. Patients who would
normally have been turned down for bypass surgery because of extensive disease,
or who are unfit for an operation, can now be offered biliary decompression by
either the percutaneous transhepatic or the endoscopic route. Endoscopic stenting,
the more recent of the two techniques, was initially limited to the standard
duodenoscope which allowed placement of only small size stents (5-7F), and was
associated with a high incidence of blockage and cholangitis1. The situation has
now changed with the availability of the large channel (3.8 mm and 4.2 mm)
duodenoscopes. In uncontrolled studies endoscopic stenting in expert hands has
yielded similar results to PTE2’3, and has beome a serious contender in the manage-
ment of these patients.
The study by Speer and colleagues, the first controlled study comparing these
two stenting techniques, concluded in favour of EP and thus seems to substantiate
claims that this is the safer procedure. The results of endoscopic stenting in this
study are most enviable and reflect the expertise of this group who are acknow-
ledged world authorities with this particular technique. On the other hand, their
complication rate for PTE is the highest published to date, and was mostly related
to bile leakage. Bile leakage was responsible for 10 of the 19 complications (3 of
8 failures and 7 of 25 successful insertions) and six (60%) of these patients died.HPB INTERNATIONAL 169
Bile leakage after failed stenting is understandable but it is not clear why 7 of the
25 patients who had "successful placement of stents" developed this complication.
In our controlled study
4 the incidence of bile leakage was significantly lower (1 of
25.p<0.05 Fisher’s 2 tail) and is probably attributable to routine embolisation of
the liver puncture tract with an "Ivalon" pledget (polyvinyl alcohol Cook inc)-
a technique not used in the present study. While the high incidence of complica-
tions may in part be explained by careful documentation, it is conceivable that the
endoscopic experts had an advantage over their PTE counterparts.
This paper highlights the problem of interpretation of studies where technical
expertise is a major determining factor in the outcome of results, even in a
controlled trial setting. The results produced by referral centres may also be
skewed by the referral pattern. We are not told what investigations patients
underwent before they were referred for treatment but, it is possible, that a degree
of selection took place in terms of suitability for stenting. By the same token, the
timing of randomisation may also have had an influence on the selection of patients
for the trial. With these provisos, the data presented by Speer and colleagues
support their conclusion regarding the advantages of endoscopic stenting over
PTE. Endoscopic stenting is safer and has fewer complications, even when the
procedure fails, and the stent is easier to replace when blockage occurs. However,
the availability of expertise and the complimentary use of both techniques in a
centre, should ensure the best chance of successful outcome. 5.
The selection of patients with advanced disease for palliative stenting remains
difficult. Many survive for only a short period and in those where the procedure
fails, complications prolong hospital stay and lead to early death. Further studies
are clearly needed to identify the risk factors for complications and those patients
who would benefit most from stenting. No clear guidelines are currently available
but it would seem ill-advised to stent patients with associated ascites (in the case
of PTE), those with extensive lesions involving the intrahepatic ducts and when
the necessary expertise with a particular technique is not available. Many patients
without associated pruritus may well be better off with appropriate supportive
measures without stenting. In the light of current knowledge such a decision should
not evoke ethical problems.
Phillipus C Bornman
Department of Surgery and Surgical Gastronterology
Groote Schuur Hostpital and University of Cape Town
Cape Town, South Africa
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